Skip to main content

Table 2 The pre- to post-treatment changes in objective markers and subjective scores

From: Evaluation of the efficacy of drug treatment based on measurement of the oxidative stress, using reactive oxygen metabolites and biological antioxidant potential, in children with autism spectrum disorder and attention deficit hyperactivity disorder

All subjectsBeforeAfterChangeap b
d-ROMs(U.CARR)413.1363.349.8<.001
BAP (μmol/L)2521.52403.3118.20.007
BAP/d-ROMs6.166.65−0.50<.001
ADHD-RS27.415.4012.00<.001
PARS-TR21.313.28.18<.001
4–6 years
 d-ROMs(U.CARR)443.8381.662.20.004
 BAP (μmol/L)2679.62467.4212.10.05
 BAP/d-ROMs6.136.51−0.380.13
 ADHD-RS24.717.47.220.14
 PARS-TR19.412.37.110.008
7–14 years
 d-ROMs(U.CARR)406.3359.247.1<.001
 BAP (μmol/L)2486.823,891.297.60.03
 BAP/d-ROMs6.166.68−0.52<.001
 ADHD-RS28.015.013.00<.001
 PARS-TR21.713.38.4<.001
  1. aChange is the score obtained by subtracting the score after treatment from the score before treatment
  2. b Wilcoxon signed-rank test was used to compute p-values